Andrew N Schiff - Net Worth and Insider Trading
Andrew N Schiff Net Worth
The estimated net worth of Andrew N Schiff is at least $93 Million dollars as of 2024-11-29. Andrew N Schiff is the Director of ZELTIQ Aesthetics Inc and owns about 1,610,879 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $91 Million. Andrew N Schiff is also the Director of Aclaris Therapeutics Inc and owns about 434,455 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $2 Million. Details can be seen in Andrew N Schiff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew N Schiff has not made any transactions after 2022-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew N Schiff
Andrew N Schiff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew N Schiff owns 18 companies in total, including Aclaris Therapeutics Inc (ACRS) , Zosano Pharma Corp (ZSANQ) , and Sunesis Pharmaceuticals Inc (SNSS) among others .
Click here to see the complete history of Andrew N Schiff’s form 4 insider trades.
Insider Ownership Summary of Andrew N Schiff
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ACRS | Aclaris Therapeutics Inc | 2022-11-14 | director |
ZSANQ | Zosano Pharma Corp | 2019-04-11 | 10 percent owner |
SNSS | Sunesis Pharmaceuticals Inc | 2019-07-15 | 10 percent owner |
2018-07-10 | 10 percent owner | ||
2017-04-28 | director & 10 percent owner | ||
2016-06-29 | 10 percent owner | ||
2014-05-23 | 10 percent owner | ||
2016-03-30 | 10 percent owner | ||
2013-12-06 | director & 10 percent owner | ||
2015-12-09 | 10 percent owner | ||
2015-04-23 | 10 percent owner | ||
2015-04-14 | 10 percent owner | ||
2015-01-27 | 10 percent owner | ||
2012-02-13 | 10 percent owner | ||
2012-02-07 | 10 percent owner | ||
2019-01-23 | 10 percent owner | ||
2021-06-24 | other: Managing Member | ||
2021-06-23 | director |
Andrew N Schiff Latest Holdings Summary
Andrew N Schiff currently owns a total of 2 stocks. Among these stocks, Andrew N Schiff owns 1,610,879 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of August 11, 2016, with a value of $91 Million and a weighting of 98.21%. Andrew N Schiff also owns 434,455 shares of Aclaris Therapeutics Inc (ACRS) as of November 14, 2022, with a value of $2 Million and a weighting of 1.79%.
Latest Holdings of Andrew N Schiff
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZLTQ | ZELTIQ Aesthetics Inc | 2016-08-11 | 1,610,879 | 56.48 | 90,982,446 |
ACRS | Aclaris Therapeutics Inc | 2022-11-14 | 434,455 | 3.82 | 1,659,618 |
Holding Weightings of Andrew N Schiff
Andrew N Schiff Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew N Schiff has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 500,000 shares on August 11, 2016, which brought Andrew N Schiff around $18 Million.
According to the SEC Form 4 filings, Andrew N Schiff has made a total of 6 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Aclaris Therapeutics Inc is the sale of 53,926 shares on November 14, 2022, which brought Andrew N Schiff around $919,438.
Insider Trading History of Andrew N Schiff
- 1
Andrew N Schiff Trading Performance
GuruFocus tracks the stock performance after each of Andrew N Schiff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew N Schiff is -20.99%. GuruFocus also compares Andrew N Schiff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew N Schiff within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew N Schiff's insider trading performs compared to the benchmark.
Performance of Andrew N Schiff
Andrew N Schiff Ownership Network
Andrew N Schiff Owned Company Details
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Andrew N Schiff is the director of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Andrew N Schiff made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net sale of 18,000 shares made by Joseph Monahan , and a net purchase of 666,666 shares made by Anand Mehra .
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 666,666 shares, with a net purchase of 666,666 shares. During the past 18 months, 18,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 5,544,913 shares were bought by its insiders, resulting in a net purchase of 5,526,913 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
Andrew N Schiff Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew N Schiff. You might contact Andrew N Schiff via mailing address: Planet Zanett Inc, 135 E 57th St, New York Ny 10022.